ROY STILES: Open Payments
NPI 1811523285 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 52 payments from 11 companies in 2025. Trend: 2023 $1,012 · 2024 $807 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $344 |
| Actelion Pharmaceuticals US, Inc. | 6 | $138 |
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| Alnylam Pharmaceuticals Inc. | 6 | $114 |
| Merck Sharp & Dohme LLC | 5 | $81 |
| BridgeBio Pharma, Inc. | 3 | $55 |
| HEARTFLOW, INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
Products named: VYNDAQEL, ELIQUIS, LEQVIO, AMVUTTRA, VERQUVO, UPTRAVI, OPSUMIT, Attruby.
Industry payments across AR — which companies pay providers there.
